Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 4, 2014, Pages 559-567

  Coppola, N ^a   Marrone, A ^a   Pisaturo, M ^a   Starace, M ^a   Signoriello, G ^a   Gentile, I ^b   Adinolfi, L E ^a   Sagnelli, E ^a   Zampino, R ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; ALPHA2B INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 28B; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS DNA; IL28B PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; MIXED INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; RETROSPECTIVE STUDY; VIRAL CLEARANCE; VIRUS REPLICATION; GENETICS; IMMUNOLOGY; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; VIROLOGY;

ADULT; COINFECTION; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 84896959418     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1985-7     Document Type: Article

References (42)

1. Tiollais P, Pourcel C, Dejean A (1985) The hepatitis B virus. Nature 317:489-495 (Pubitemid 16224154)
2. Dienstag JL (1993) Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85:439-462
3. Kaczynski J, Hansson G, Wallerstedt S (1996) Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 73:128-132 (Pubitemid 26026274)
4. Filippini P, Coppola N, Pisapia R,Martini S,Marrocco C, Di Martino F, et al (2007) Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients. J Med Virol 79:1679-1685 (Pubitemid 47479886)
5. Sato S, Fujiyama S, Tanaka M, Yamasaki K, Kuramoto I, Kawano S et al (1994) Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 21:159-166 (Pubitemid 24270539)
6. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A et al (1993) Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 105:1529-1533 (Pubitemid 23315331)
7. Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T et al (2000) Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 32:1106-1110
8. Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A et al (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis.Aprospective study. Cancer 74:2442-8 (Pubitemid 24320846)
9. Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM et al (1995) Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 2:39-45
10. Sagnelli E, Pasquale G, Coppola N, Scarano F, Marrocco C, Scolastico C et al (2004) Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection 32:144-148 (Pubitemid 38757018)
11. Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C et al (2006) Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 43:100-107 (Pubitemid 43733596)
12. Sheen IS, Liaw YF, Lin DY, Chu CM (1994) Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 170:358-361
13. Zampino R, Marrone A, Merola A, Trani B, Cirillo G, Karayiannis P et al (2009) Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth. J Med Virol 81:2012-2020
14. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C et al (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798-801
15. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ et al (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-401
16. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N et al (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41:1105-1109
17. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML et al (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41:1100-1104
18. Zampino R, Coppola N, Cirillo G, Boemio A, Pisaturo M, Marrone A et al (2013) Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. J Viral Hepat 20:517-523
19. Coppola N, Zampino R, Bellini G, Macera M, Marrone A, Pisaturo M et al (2013) Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C. Clin Gastroenetrol Hepatol. doi:10.1016/j.cgh.2013.05.008
20. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699
21. Carosi G, Rizzetto M (2008) Treatment of chronic hepatitis B: recommendations from an Italian workshop. Dig Liver Dis 40:603-617
22. Italian Association for the Study of the Liver; Italian Society of Infectious, Tropical Diseases; Italian Society for the Study of Sexually Transmitted Diseases (2010) Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. Dig Liver Dis 42:81-91
23. Coppola N, Pisaturo M, Tonziello G, Sagnelli C, Sagnelli E, Angelillo IF (2012) Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis. BMC Infect Dis 12:357. doi:10.1186/1471-2334-12-357
24. Coppola N, Tonziello G, Pisaturo M, Messina V, Guastafierro S, Fiore M et al (2011) Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. J Med Virol 83:1909-1916
25. Coppola N, Pisaturo M, Guastafierro S, Tonziello G, Sica A, Iodice V et al (2012) Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy. Dig Liver Dis 44:49-54
26. Coppola N, Potenza N, Pisaturo M, Mosca N, Tonziello G, Signoriello G et al (2013) Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression. PLoS One 8:e65336. doi:10.1371/journal.pone.0065336
27. Coppola N, Masiello A, Tonziello G, Pisapia R, Pisaturo M, Sagnelli C et al (2010) Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. J Viral Hepat 17:493-500
28. Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD et al (2010) A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 139:1586-1592
29. Sagnelli E, Pisaturo M, Stanzione M, Messina V, Alessio L, Sagnelli C et al (2013) Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C. Clin Gastroenterol Hepatol 11:1174-1180
30. Balagopal A, Thomas DL, Thio CL (2010) IL28B and the control of hepatitis C virus infection. Gastroenterology 139:1865-1876
31. Mathurin P, Thibault V, Kadidja K, Ganne-Carrié N, Moussalli J, El Younsi M et al (2000) Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat 7:15-22 (Pubitemid 30139847)
32. Coppola N, Pisapia R, Tonziello G, Martini S, Imparato M, Piai G et al (2008) Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection. Antivir Ther 13:307-318 (Pubitemid 351535382)
33. Liaw YF, Yeh CT, Tsai SL (2000) Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 95:2978-2980
34. Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A et al (2002) HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology 36:1285-1291 (Pubitemid 35253448)
35. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM (2004) Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 126:1024-1029
36. Sagnelli E, Coppola N, Marrocco C, Onofrio M, Sagnelli C, Coviello G et al (2006) Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course. J Clin Virol 35:317-20 (Pubitemid 43188980)
37. Sagnelli E, Coppola N, Pisaturo M, Pisapia R, Onofrio M, Sagnelli C, et al. (2006) Clinical and virological improvement of HBV or HCV related chronic hepatitis with concomitant HAV infection. Clin Infect Dis 42:1536-1543
38. Sagnelli E, Coppola N, Pisaturo M, Masiello A, Tonziello G, Sagnelli C et al (2009) HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV. Hepatology 49:1090-1097
39. Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J et al (2008) The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection. J Hepatol 49:688-694
40. Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS et al (2009) Peginterferon Alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 136:496-504.e3
41. Coppola N, Stanzione M, Messina V, Pisaturo M, De Pascalis S, Macera M et al (2012) Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection. J Viral Hepat 19:890-896
42. Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH et al (2013) Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology 57:2134-2142